Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2010

View Archived Issues

Medivir identifies novel BACE1 inhibitors

Banyu and Merck & Co. disclose novel NFkappaB-inducing kinase inhibitors

Novel CGRP antagonists claimed by Merck & Co.

Merck & Co. discloses novel positive allosteric modulators of M1 receptors

Actelion identifies novel antibacterial agents

Novel CRAC inhibitor synthesized at Incozen Therapeutics

FDA approves Chagas' disease screening test

Affimed raises funds in Series C financing round

Omeros' OMS-103HP shows clinical benefits in phase II trial in arthroscopic meniscectomy surgery

TB Alliance and AstraZeneca enter collaboration agreement for TB drug discovery and development

BioSante reinitiates development of GVAX prostate cancer vaccine

Cullin-1 emerges as a potential biomarker for the early diagnosis of human melanoma

Antisense Therapeutics provides update on pipeline candidates

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

FDA approves new dosing guidance for Creon in patients with chronic pancreatitis and pancreatectomy

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

LiGluR gene therapy reinstates visual responses in inherited blindness models

K-V Pharmaceutical provides update on confirmatory trial of Gestiva

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

King and Acura to submit an NDA for Acurox tablets without Niacin

NOXXON completes first phase I study of Spiegelmer NOX-A12

FDA issues complete response letter to Sepracor's NDA for Stedesa

Curis completes enrollment and treatment in phase I study of CUDC-101 in cancer

Celator reports data from phase II Cpx-351 study in acute myeloid leukemia

FDA grants Osiris orphan drug designation for Prochymal in type 1 diabetes

ImmunoCellular files orphan drug application for ICT-107

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...